Mass casualty blood supply chain simulator — donation to transfusion under massive transfusion protocol strain
Every unit of blood transfused in a mass casualty event began as a voluntary donation, often weeks earlier, that moved through collection, testing, component separation, and refrigerated storage before ever reaching a trauma bay. Understanding this baseline cold chain — and how thin the O-negative buffer really is — explains why supply collapses so quickly once a surge begins.
A unit of blood travels a long pipeline before it can save a trauma patient's life: donor recruitment and screening → phlebotomy collection (~450–500 mL whole blood) → infectious disease and ABO/Rh testing → component separation by centrifugation into red cells, plasma, and platelets → refrigerated or frozen storage → distribution to hospital blood banks → bedside crossmatch and issue → transfusion.
Each step takes time. From donation to a unit being available on a hospital shelf typically takes 1–3 days for red cells (testing and processing) and longer for plasma, which is frozen and must later be thawed. This lag is precisely why a hospital cannot simply "ask for more blood" the moment a mass casualty incident begins — the pipeline that will eventually resupply it was already in motion long before, and what matters in the first hours is only what is already sitting in the fridge.
Blood is not one product — it is several biologically distinct components, each with its own fragile storage window:
• Packed red blood cells (PRBCs): stored at 1–6°C in an additive solution (e.g., AS-1); shelf life up to 42 days. Cold storage slows metabolic breakdown but red cells still progressively lose 2,3-DPG and ATP ("storage lesion"). • Platelets: stored at 20–24°C (room temperature) under continuous gentle agitation to prevent aggregation; shelf life only 5 days classically, extended to 7 days where pathogen-reduction or bacterial-detection testing is used. Warm storage makes platelets the most bacteria-vulnerable component. • Fresh frozen plasma (FFP): frozen at −18°C or colder within hours of collection; shelf life up to 1 year frozen, but once thawed must be used within 24 hours (or up to 5 days if kept at 1–6°C in some protocols). • Cryoprecipitate: the cold-insoluble fraction of thawed plasma, rich in fibrinogen and Factor VIII; frozen shelf life ~1 year, but once thawed and pooled must be used within 4–6 hours.
A hospital blood bank must therefore juggle several parallel cold chains simultaneously, each with a different expiration clock, to keep a balanced inventory ready.
A single trauma patient in hemorrhagic shock can consume an entire hospital's 5-day supply of platelets in one resuscitation — platelets cannot be stockpiled the way red cells can, because their shelf life is roughly one-eighth as long.
Hospital blood banks stock inventory roughly proportional to population blood-type frequency: O-positive (~38%) and A-positive (~34%) dominate; O-negative, despite being clinically indispensable, is only ~7% of donors. AB-negative is rarest at under 1%.
Because O-negative red cells carry neither A, B, nor Rh(D) antigens, they can be transfused into any recipient without triggering an ABO/Rh incompatibility reaction — making O-negative the default "emergency release" blood issued to any critically bleeding patient before their own blood type is known. This clinical necessity means O-negative is drawn down far faster, relative to its stock size, than any other type — a structural imbalance that exists even on a completely ordinary day, long before any mass casualty event begins.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Packed Red Blood Cells (PRBC) | |||
| Fresh Frozen Plasma (FFP) | |||
| Platelets | |||
| Cryoprecipitate |
A mass casualty incident does not present one bleeding patient at a time — it presents many, all at once, all competing for the same finite refrigerator of blood. When several patients simultaneously meet Massive Transfusion Protocol (MTP) criteria, a hospital that normally issues a handful of units per hour must suddenly issue dozens within minutes.
MTP is a standardized, pre-packaged hospital response to catastrophic hemorrhage, triggered when a patient's blood loss outpaces what routine, one-unit-at-a-time ordering can keep up with. Classic definitions include:
• ≥10 units of PRBCs within 24 hours (roughly a full adult blood volume) • ≥4 units of PRBCs within 1 hour with ongoing need anticipated • More recently, the Critical Administration Threshold (CAT): ≥3 units of PRBCs in any rolling 15-minute period — designed to trigger MTP earlier, before the patient has already received 10 units
Once activated, MTP releases pre-defined coolers of blood products (rather than single units ordered one at a time) directly to the trauma bay or OR, bypassing normal step-by-step ordering to save minutes that matter when a patient is losing a unit of blood every few minutes.
Because MTP activation consumes scarce inventory, hospitals use rapid bedside scoring tools to decide who truly needs it, especially when multiple patients arrive together:
• Shock Index (heart rate ÷ systolic blood pressure): a value >0.9–1.0 suggests significant hemorrhagic shock • ABC score (Assessment of Blood Consumption): penetrating mechanism, positive FAST ultrasound, shock index ≥1, systolic BP ≤90 mmHg — 2 or more positive predictors flags likely MTP need • Base deficit and lactate on arterial blood gas: markers of tissue hypoperfusion from blood loss
In a mass casualty scenario, these tools must be applied to many patients within minutes, and multiple patients can legitimately trigger MTP simultaneously — the exact scenario that overwhelms a normal-sized blood bank inventory built for one or two trauma activations at a time, not a dozen.
The October 2017 mass shooting at the Route 91 Harvest festival in Las Vegas sent hundreds of gunshot-wound patients to Las Vegas-area trauma centers within a span of roughly two hours. Hospitals activated mass casualty and massive transfusion protocols repeatedly through the night, drawing down blood bank shelves at a rate far exceeding any single day's normal usage. Local blood centers issued urgent public appeals for donations within hours of the incident, and hospital blood banks coordinated emergency shipments from sister facilities to keep pace with ongoing MTP activations.
The event is now a widely cited case study in disaster medicine for two lessons: first, that a single mass casualty incident can consume a multi-day blood supply in a single night; and second, that public donation surges after a disaster — while generous — arrive too late to help the first critical hours, which depend entirely on pre-positioned inventory and regional mutual aid.
A hospital blood bank stocked for an ordinary trauma day can be pushed through its entire O-negative reserve, and a large share of its total inventory, by a handful of simultaneous MTP activations — a single mass casualty incident can outstrip in hours what routine practice draws down over a week.
When a trauma patient arrives too unstable for the ~10–45 minutes a full type-and-crossmatch requires, clinicians cannot wait — they issue O-negative red cells immediately as an "emergency release," safe for any recipient regardless of blood type. That safety margin comes at a structural cost: O-negative is consumed far faster than its 7% share of the donor pool can replace.
Red blood cells carry ABO antigens (A, B, both, or neither) and the Rh(D) antigen. Transfusing incompatible ABO blood can trigger a fatal acute hemolytic reaction within minutes. Full compatibility testing — ABO/Rh typing, antibody screen, and crossmatch — takes roughly 45–60 minutes when done properly, time a patient bleeding out from a gunshot wound or crush injury does not have.
O-negative red cells lack A, B, and D antigens entirely, so they cannot provoke an ABO/Rh mismatch reaction in any recipient. This makes O-negative the default "emergency release" product handed to trauma teams the moment a patient's hemorrhage is recognized as life-threatening — often before the patient's name, let alone their blood type, is confirmed. In a mass casualty event with multiple simultaneously unstable patients of unknown type, this single blood type becomes the shared emergency reserve for the entire incident.
The imbalance is structural, not incidental: O-negative donors make up roughly 7% of the population, yet emergency-release protocols route a disproportionate share of early trauma transfusions through this single type. A blood bank stocked in rough proportion to population frequency will therefore always hold its thinnest buffer in precisely the product an MCI depletes fastest.
Hospital blood banks mitigate this in two ways: switching each patient to their own confirmed type-specific blood the moment typing results return (usually within 15–20 minutes), and reserving O-negative specifically for women of childbearing age and patients of truly unknown type — while shifting male patients of unknown type to O-positive emergency release instead, since Rh sensitization is a lower-stakes risk for them. This "switch to type-specific ASAP" discipline is often the single most effective inventory-conservation move available once a surge begins.
O-negative donors represent roughly 7% of the population but are called on to cover a share of emergency trauma transfusions many times larger — a mismatch that means the O-negative shelf is typically the first shelf to empty in any mass casualty response, regardless of how large the total blood supply is.
One emerging solution is low-titer O (LTOWB) whole blood — group O blood screened to confirm low anti-A/anti-B antibody titers, so it can be transfused as a single, unseparated product to patients of any type without first splitting it into components. Because it delivers red cells, plasma, and platelets together in their natural ratio, a single unit of whole blood does the resuscitative work of three separate component units, stretching a limited O-negative-adjacent supply further per patient — a lesson pulled directly from military combat casualty care, discussed further in the next stage.
Once on-hand inventory nears exhaustion, a blood bank pulls three levers simultaneously: activating mutual-aid shipments from regional blood centers, opening emergency mobile collection drives, and — in the most extreme shortfalls — standing up a "walking blood bank" of pre-screened staff and bystanders who donate fresh whole blood on site, a technique refined in military combat casualty care.
Hospital blood banks do not operate in isolation — most participate in formal regional and national mutual-aid networks (coordinated in the US through organizations like AABB and regional blood centers such as the American Red Cross and Vitalant) that allow one facility to request emergency shipments from another within the same disaster response. When a mass casualty incident is declared, these networks can redirect inventory from unaffected hospitals and regional distribution centers by ground courier or, for the most time-critical shortfalls, by helicopter.
This is the fastest scalable resupply lever available in the first hours: it draws on blood that has already completed testing and processing and is sitting ready on a shelf elsewhere, rather than blood that must first be newly collected and screened.
Mass casualty events reliably trigger a surge of public donations — community members lining up at blood centers within hours of a disaster being reported. This generosity is real, but it comes with a timing paradox: donated blood must still be tested, processed, and typed before it can be released for transfusion, a process that takes at least 24–48 hours even under emergency workflows. The patients bleeding out in the first hours of the incident will never receive blood from that same day's donation surge.
Blood centers manage this by asking the public to schedule donations over the following days and weeks rather than all rushing in at once — replenishing the pipeline for the days after the event, when regional shipments and immediate reserves have been drawn down, rather than for the acute event itself.
When regional shipments cannot arrive fast enough, some trauma centers and military forward surgical teams activate a "walking blood bank": a roster of pre-screened staff, first responders, or bystanders with known or rapidly testable blood type, drawn from directly at the point of care as fresh whole blood.
This approach was refined by the US military's "Ranger O Low Titer" program, in which soldiers pre-identified as low-titer group O donors carry documented blood-type cards and can be drawn on the battlefield to provide immediately transfusable whole blood to wounded comrades when banked blood products are unavailable — a practice tracing back to World War I and revived for modern combat casualty care in Iraq and Afghanistan.
Fresh whole blood delivers red cells, plasma, and platelets in one unrefrigerated unit, must be transfused within hours of collection (no time for component separation or cold storage), and — while logistically demanding and reserved for true last-resort shortfalls — has repeatedly proven lifesaving when the cold chain simply cannot deliver components fast enough.
The walking blood bank model shows up wherever banked blood cannot arrive in time — from World War I field hospitals to modern combat casualty care to civilian mass casualty response — because a healthy human being can, in an emergency, still be the fastest blood bank in existence.
When supply cannot fully meet demand, trauma teams shift from "give more blood" to "give blood smarter" — resuscitating with a balanced ratio of red cells, plasma, and platelets that mimics whole blood, adding tranexamic acid to reduce how much blood is needed in the first place, and directing what remains toward the patients most likely to survive.
For decades, trauma resuscitation leaned heavily on red cells and crystalloid fluids, with plasma and platelets given later and in smaller amounts. This diluted clotting factors and worsened the "lethal triad" of trauma: coagulopathy, hypothermia, and acidosis.
The Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial (Holcomb et al., JAMA 2015) randomized 680 severely injured trauma patients to receive blood products in a 1:1:1 ratio (plasma:platelets:PRBC) versus a 1:1:2 ratio. The 1:1:1 group achieved significantly better hemostasis and fewer deaths from exsanguination within 24 hours (9.2% vs 14.6%), even though overall 24-hour and 30-day mortality did not differ significantly between groups. This evidence cemented the 1:1:1 "damage control resuscitation" ratio — mirroring the composition of whole blood — as the standard massive transfusion protocol target across trauma centers.
When supply is short, this ratio becomes a rationing discipline as much as a clinical target: allocating scarce plasma and platelets proportionally alongside red cells, rather than exhausting red cells first and leaving no clotting support for later patients.
The PROPPR trial showed that HOW blood products are combined — not just how many units are given — measurably changes survival: a 1:1:1 ratio cut 24-hour deaths from bleeding by roughly a third compared to a red-cell-heavy 1:1:2 ratio.
Tranexamic acid (TXA) is an antifibrinolytic drug that stabilizes blood clots by blocking the enzyme systems that break them down, reducing ongoing bleeding without needing an extra unit of blood. The CRASH-2 trial (Lancet, 2010), which randomized 20,211 trauma patients across 40 countries, found that TXA given within 3 hours of injury reduced death due to bleeding by roughly one-third, with a modest but significant reduction in all-cause mortality — while TXA given after 3 hours showed no benefit and a trend toward harm.
In a supply-constrained mass casualty event, TXA is uniquely valuable precisely because it does not draw on the blood bank at all: it is cheap, shelf-stable, and can be given by paramedics in the field before a patient ever reaches the hospital, reducing the total transfusion burden that will later compete for scarce O-negative and balanced-ratio components.
When component inventory genuinely cannot cover every patient who could benefit, trauma and disaster-medicine triage frameworks direct remaining units toward patients with the highest survivability given the resources available — deliberately not always the most severely injured patient, since resuscitating a nonsurvivable injury can consume the entire remaining O-negative reserve while several moderately injured patients go unsupported.
This "greatest good for the greatest number" principle, formalized in mass casualty triage systems (e.g., SALT, START), extends naturally into blood product rationing: a running coverage gauge — comparing units on hand against ongoing MTP demand — lets blood bank and trauma leadership make transparent, real-time allocation decisions rather than simply issuing product until the shelves are empty.